Tumor microenvironment modulation enhances immunologic benefit of chemoradiotherapy
Abstract Background Chemoradiotherapy (CRT) remains one of the most common cancer treatment modalities, and recent data suggest that CRT is maximally effective when there is generation of an anti-tumoral immune response.However, CRT has also been shown to promote immunosuppressive mechanisms which must be blocked or reversed to maximize its immune